NCT02983500

Patient Reported Outcomes Registry in Patient With Cancer Cachexia

Tablet-based Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced NSCLC or Advanced Pancreatic Cancer With Focus on Cancer Cachexia

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 253 (actual)
• Sponsor: iOMEDICO AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Evaluation of patient reported outcomes (PRO) with tumor cachexia in a real life setting.

Detailed description

The PRO Xie project will recruit a representative cohort of patients with advanced lung or advanced pancreatic cancer with a high risk for the development of cancer cachexia. Patient Reported Outcomes (PRO) are assessed in a real life setting by a questionnaire consisting of 20 questions: QoL is measured by SF12, fatigue by FACIT-F and cachexia by FAACT questionnaires, respectively. These data will determine the potential need for anti-cachexia treatment in those patients, as well as the number of underweight patients, the evaluation of general QoL, fatigue and cachexia and the evaluation of malnutrition.

Conditions

• Metastatic Pancreatic Cancer
• NSCLC, Metastatic

Timeline

• Start date: 2016-08-28
• Primary completion: 2019-07-24
• Completion: 2019-07-24
• First posted: 2016-12-06
• Last updated: 2020-08-07

Locations

1 site across 1 country: Germany